ClinicalThought

Share

Program Content

Activities

  • Nivolumab ± Ipilimumab in Advanced SCLC
    Immunotherapy: An Intriguing Work in Progress for the Treatment of Advanced SCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AbbVie

Bristol Myers Squibb